跳至主要内容
临床试验/NL-OMON33406
NL-OMON33406已完成不适用

Microbiological and clinical evaluation of different implant surface decontaminating procedures in the surgical treatment of peri-implantitis; a double blind placebo controlled randomized clinical study. - Implant surface decontamination in peri-implantitis treatment

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) The patient is >= 18 years of age;
  • 2) The patient has at least one endosseous implant in the oral cavity with clinical and radiographical signs of peri-implantitis. Peri-implantitis is defined as a loss of marginal bone >= 2 mm as compared to a fixed reference point on the dental implant, in combination with bleeding and/or suppuration on probing and a peri-implant probing depth >= 5 mm;
  • 3) The implants have been exposed to the oral environment for at least two years;
  • 4) The patient is capable of understanding and giving informed consent.

排除标准

  • 1) Medical and general contraindications for the surgical procedures;
  • 2) A history of local radiotherapy to the head and neck region;
  • 3) Pregnancy and lactation;
  • 4) Diabetes;
  • 5) Systemic use of antibiotics during the last 3 months;
  • 6) Long-term use of anti-inflammatory drugs;
  • 7) Incapability of performing basal oral hygiene measures as a result of physical or mental disorders;
  • 8) Active, uncontrolled periodontal pathology of the remaining dentition;
  • 9) Local use of antibiotics or use of other anti-septic / antimicrobial therapies in the oral cavity during the last 3 months;
  • 10) Use of mouthrinses;
  • 11) Bruxism;
  • 12) Implants placed in skin grafted areas;
  • 13) Implants with bone loss due to other reasons than bacterial infection (e.g. loose screw, inadequate positioning of the implant);
  • 14) Implants with bone loss exceding 2/3 of the length of the implant or implants with bone loss beyond the transverse openings in hollow implants;
  • 15) Implant mobility;
  • 16) Implants at which no postition can be identified where proper probing measurements can be performed;
  • 17) Previous surgical treatment of the peri-implantitis lesions;
  • 18) Previous non-surgical treatment of the peri-implantitis lesions during the last 6 months (scaling or curretage).

研究者

相似试验